SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-101051
Filing Date
2010-11-04
Accepted
2010-11-04 17:27:01
Documents
10
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b82695e10vq.htm 10-Q 564633
2 EX-31.1 SECTION 302 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER b82695exv31w1.htm EX-31.1 8772
3 EX-31.2 SECTION 302 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER b82695exv31w2.htm EX-31.2 8771
4 EX-32.1 SECTION 906 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER b82695exv32w1.htm EX-32.1 3816
5 EX-32.2 SECTION 906 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER b82695exv32w2.htm EX-32.2 3863
  Complete submission text file 0000950123-10-101051.txt   1993815

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT alny-20100930.xml EX-101.INS 199232
7 EX-101 SCHEMA DOCUMENT alny-20100930.xsd EX-101.SCH 10460
8 EX-101 CALCULATION LINKBASE DOCUMENT alny-20100930_cal.xml EX-101.CAL 33453
9 EX-101 LABELS LINKBASE DOCUMENT alny-20100930_lab.xml EX-101.LAB 119975
10 EX-101 PRESENTATION LINKBASE DOCUMENT alny-20100930_pre.xml EX-101.PRE 66480
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50743 | Film No.: 101165972
SIC: 2834 Pharmaceutical Preparations